Cargando…
Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial
INTRODUCTION: There are several randomised controlled trials (RCTs) that have already shown that metabolic/bariatric surgery achieves short-term and long-term glycaemic control while there are no level 1A of evidence data regarding the effects of surgery on the microvascular complications of type 2...
Autores principales: | Cohen, Ricardo Vitor, Pereira, Tiago Veiga, Aboud, Cristina Mamédio, Caravatto, Pedro Paulo de Paris, Petry, Tarissa Beatrice Zanata, Correa, José Luis Lopes, Schiavon, Carlos Aurélio, Correa, Mariangela, Pompílio, Carlos Eduardo, Pechy, Fernando Nogueira Quirino, le Roux, Carel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253594/ https://www.ncbi.nlm.nih.gov/pubmed/28077412 http://dx.doi.org/10.1136/bmjopen-2016-013574 |
Ejemplares similares
-
Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial
por: Cohen, Ricardo V., et al.
Publicado: (2021) -
Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trial
por: Cohen, Ricardo V., et al.
Publicado: (2022) -
Effect of duodenal-jejunal bypass surgery on glycemic control in type 2 diabetes: a randomized controlled trial
por: Petry, Tarissa Z., et al.
Publicado: (2015) -
Smart Mom, Rich Mom
por: Palmer, Kimberly
Publicado: (2016) -
Urinary Metabolomic Changes Accompanying Albuminuria Remission following Gastric Bypass Surgery for Type 2 Diabetic Kidney Disease
por: Martin, William P., et al.
Publicado: (2022)